| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Dec―22 |
SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-κB activation |
Marie J Tofaute, Benjamin Weller, Carina Graß, Hridi Halder, Bushra Dohai, Pascal Falter-Braun, Daniel Krappmann |
| 2 |
[GO] |
2023―Jul―27 |
Surfactant Replacement Therapy as Promising Treatment for COVID-19: an Updated Narrative Review |
Khaled Kh�h, Alaa Ramadan, Ahmed Othman, Neveen Refaey, Amr Alrosasy, Ayoub Rezkallah, Toka Heseba, Mostafa Hossam El Din Moawad, Ammar Mektebi, Sewar A Elejla, Mohamed Abouzid, Basel Abdelazeem |
| 3 |
[GO] |
2023―Jul―24 |
The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy |
Abdulla Abu-Bakr Badawy |
| 4 |
[GO] |
2023―May―22 |
COVID-19 Associated Thyroid Dysfunction and Other Comorbidities and Its Management Using Phytochemical-Based Therapeutics- A Natural Way |
Arpana Parihar, Shivani Malviya, Raju Khan, Ajeet Kaushik, Ebrahim Mostafavi |
| 5 |
[GO] |
2023―Mar―06 |
Acid-Base Imbalance as a Risk Factor for Mortality among COVID-19 Hospitalized Patients |
Nosayba Al-Azzam, Basheer Khassawneh, Sayer Al-Azzam, Reema Karasneh, Mamoon A Aldeyab |
| 6 |
[GO] |
2023―Jan―18 |
Polypharmacology of ambroxol in the treatment of COVID-19 |
Ziyuan Wang, Minghui Yang, Xi Chen, Rongxin Xiao, Yu Dong, Ming Chu, Guojie Song, Yuedan Wang |
| 7 |
[GO] |
2021―Sep―14 |
Targeting Intra-Viral Conserved Nucleocapsid (N) Proteins as Novel Vaccines against SARS-CoVs |
Min Thura, Joel Xuan En Sng, Koon Hwee Ang, Jie Li, Abhishek Gupta, Jimmy Ming Hong, Cheng William Hong, Qi Zeng |
| 8 |
[GO] |
2021―Aug―05 |
Obesity, a major risk factor for immunity and severe outcomes of COVID-19 |
Mohammad Tohidul Amin, Kaniz Fatema, Sayama Arefin, Fahad Hussain, Dipty Rani Bhowmik, Mohammad Salim Hossain |
| 9 |
[GO] |
2021―Jul―30 |
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 |
Lize M Grobbelaar, Chantelle Venter, Mare Vlok, Malebogo Ngoepe, Gert J Laubscher, Petrus J Lourens, Janami Steenkamp, Douglas Kell, Etheresia Pretorius |
| 10 |
[GO] |
2021―Jul―27 |
A lipidomic view of SARS-CoV-2 |
Kourosh Honarmand Ebrahimi, James McCullagh |
| 11 |
[GO] |
2021―Jul―22 |
Biochemical composition, transmission and diagnosis of SARS-CoV-2 |
Rajesh Ahirwar, Sonu Gandhi, Komal Komal, Geeta Dhaniya, Prem Prakash Tripathi, Vyas Madhavrao Shingatgeri, Krishan Kumar, Jai Gopal Sharma, Saroj Kumar |
| 12 |
[GO] |
2021―Jul―01 |
Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 |
Aline H de Nooijer, Inge Grondman, Simon Lambden, Emma J Kooistra, Nico AF Janssen, Matthijs Kox, Peter Pickkers, Leo AB Joosten, Frank van de Veerdonk, Marc Derive, Sebastien Gibot, Mihai G Netea |
| 13 |
[GO] |
2021―Jun―16 |
Heparanase as a Potential Player in SARS-CoV-2 Infection and Induced-Coagulopathy |
Safa Kinaneh, Iyad Khamaysi, Tony Karram, Shadi Hamoud |
| 14 |
[GO] |
2021―Feb―26 |
Lipidomic Alteration of Plasma in Cured COVID-19 Patients using UltraHigh-Performance Liquid Chromatography with High-Resolution Mass Spectrometry |
Yunpeng Bai, Wendong Huang, Yaocai Li, Changchun Lai, Sumei Huang, Guangwen Wang, Yuemei He, Linhui Hu, Chunbo Chen |
| 15 |
[GO] |
2021―Feb―24 |
Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates |
Mateus S.M. Serafim, Jadson C. Gertrudes, Débora M. A. Costa, Patricia R. Oliveira, Vinicius G. Maltarollo, Kathia Maria Honorio |
| 16 |
[GO] |
2021―Feb―24 |
The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage |
Junfang Wu, Mingming Zhao, Chenze Li, Yuxuan Zhang, Dao Wen Wang |
| 17 |
[GO] |
2021―Feb―23 |
Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 |
|
| 18 |
[GO] |
2021―Jan―23 |
Hyperglycaemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: A meta-analysis |
Yan Yang, Zixin Cai, Jingjing Zhang |
| 19 |
[GO] |
2021―Jan―14 |
ACE/ACE2 balance might be instrumental to explain the certain comorbidities lead to severe COVID-19 cases |
Sarbashri Bank, Subrata Kumar De, Biswabandhu Bankura, Smarajit Maiti, Madhusudan Das, Gausal A Khan |
| 20 |
[GO] |
2020―Dec―22 |
Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19 |
Guolian Zhao, Yazhou Xu, Jing Li, Xiaoli Cui, Xiaowen Tan, Hongyue Zhang, Liyun Dang |
| 21 |
[GO] |
2020―Dec―11 |
Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential |
Zubair A Nizamudeen, Emma-Ruoqi Xu, Vivin Karthik, Mohamed Halawa, Kenton P Arkill, Andrew Jackson, David O. Bates, Jonas Elmsley |
| 22 |
[GO] |
2020―Nov―30 |
Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical |
Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang |
| 23 |
[GO] |
2020―Nov―17 |
Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. |
Gianluca E.M. Boari, Giulia Chiarini, Silvia Bonetti, Paolo Malerba, Gianluca Bianco, Cristina Faustini, Federico Braglia-Orlandini, Daniele Turini, Vittoria Guarinoni, Michele Saottini, Sara Viola, Giulia Ferrari-Toninelli, Giancarlo Pasini, Cristina Mascadri, Bianca Bonzi, Paolo Desenzani, Claudia Tusi, Eros Zanotti, Matteo Nardin, Damiano Rizzoni |
| 24 |
[GO] |
2020―Nov―04 |
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 |
Chun Liang, Wenhao Niu, Feng Wu, Wenyue Cao, Zonggui Wu, Yu Chieh Chao, Fei Peng |
| 25 |
[GO] |
2020―Oct―16 |
Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide? |
Abdulla A-B Badawy |
| 26 |
[GO] |
2020―Jul―29 |
Blood routine test in mild and common 2019 coronavirus (COVID-19) patients |
Dodji Kossi Djakpo, Zhiquan Wang, Rong Zhang, Xin Chen, Peng Chen, Malyn Martha Lilac ketisha Antoine |
| 27 |
[GO] |
2020―May―22 |
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19 |
Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed Alajmi, Afzal Hussain, Md. Tabish Rehman, Asimul Islam, Md. Imtaiyaz Hassan |
| 28 |
[GO] |
2020―May―07 |
A virus that has gone viral: Amino-acid mutation in S protein of Indian-isolate of Coronavirus COVID-19 might impact receptor-binding, thus infectivity |
Priyanka Saha, Arup Kumar Banerjee, Prem Prakash Tripathi, Amit Kumar Srivastava, Upasana Ray |
|
